You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CEBP Beta antibody [E299] (ab32358)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-CEBP Beta antibody [E299]
See all CEBP Beta products (10) ...

Description

Rabbit monoclonal [E299] to CEBP Beta

Specificity

This antibody is specific for the three CEBPB isoforms (LAP*, LAP and LIP).

Tested applications

EMSA, ICC, WB, ICC/IF, IPmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Synthetic peptide corresponding to residues in the C terminus of Rat CEBPB.

Positive control

WB: PC12 cell lysate. IF: Hela cells.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%

Concentration

Concentration information loading...

Clonality

Monoclonal

Clone number

E299

Isotype

IgG

  • Western blot - CEBPB antibody [E299] (ab32358)Western blot - CEBPB antibody [E299] (ab32358) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - CEBPB antibody [E299] (ab32358)Immunocytochemistry/ Immunofluorescence - CEBPB antibody [E299] (ab32358) image (enlarge)

  • Western blot - CEBP Beta antibody [E299] (ab32358)Western blot - CEBP Beta antibody [E299] (ab32358) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab32358 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

EMSA: Use at an assay dependent dilution (PMID 18462018).
ICC/IF: 1/50 - 1/100.
IP: 1/20.
WB: 1/1000. Predicted molecular weight: 36 kDa.

Is unsuitable for Flow Cyt or IHC.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Important transcriptional activator in the regulation of genes involved in immune and inflammatory responses. Specifically binds to an IL-1 response element in the IL-6 gene. NF-IL6 also binds to regulatory regions of several acute-phase and cytokines genes. It probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Functions in brown adipose tissue (BAT) differentiation.

Tissue specificity

Expressed at low levels in the lung, kidney and spleen.

Sequence similarities

Belongs to the bZIP family. C/EBP subfamily.
Contains 1 bZIP domain.

Domain

the 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.

Post-translational
modifications

Sumoylated by polymeric chains of SUMO2 or SUMO3.

Cellular localization

Nucleus.

Target information above from: UniProt accessionP17676 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • AGP/EBP antibody
  • C EBP beta antibody
  • C/EBP beta antibody
  • C/EBP related protein 2 antibody
  • CCAAT Enhancer Binding Protein beta antibody
  • CCAAT/enhancer-binding protein beta antibody
  • CEBPB antibody
  • CEBPB_HUMAN antibody
  • CRP2 antibody
  • IL 6DBP antibody
  • IL6DBP antibody
  • Interleukin 6 dependent binding protein antibody
  • LAP antibody
  • Liver activator protein antibody
  • Liver enriched transcriptional activator antibody
  • NF IL6 antibody
  • NFIL6 antibody
  • Nuclear factor NF IL6 antibody
  • Nuclear factor NF-IL6 antibody
  • SF B antibody
  • SFB antibody
  • Silencer factor B antibody
  • TCF-5 antibody
  • TCF5 antibody
  • Transcription factor 5 antibody
see all

Anti-CEBP Beta antibody [E299] images:

  Western blot - CEBPB antibody [E299] (ab32358)

Western blot - CEBPB antibody [E299] (ab32358)

Anti-CEBP Beta antibody [E299] (ab32358) at 1/1000 dilution + PC12 cell lysate.

Predicted band size : 36 kDa


Observed bands
LAP*: 38kDa
LAP: 35kDa
LIP: 20kDa

  Immunocytochemistry/ Immunofluorescence - CEBPB antibody [E299] (ab32358)

Immunocytochemistry/ Immunofluorescence - CEBPB antibody [E299] (ab32358)

Ab32358, at a 1/50 dilution, staining CEBPB in Hela cells by Immunofluorescence.

  Western blot - CEBP Beta antibody [E299] (ab32358)

Western blot - CEBP Beta antibody [E299] (ab32358)

All lanes : Anti-CEBP Beta antibody [E299] (ab32358) at 1/500 dilution

Lane 1 : 3T3 Cells
Lane 2 : MCF7 Cells
Lane 3 : PC12 Cells
Lane 4 : Rat Spleen Lysate
Lane 5 : Rat Kidney Lysate
Lane 6 : Rat Heart Lysate
Lane 7 : Rat Brain Lysate
Lane 8 : Mouse Spleen Lysate
Lane 9 : Mouse Kidney Lysate
Lane 10 : Mouse Heart Lysate
Lane 11 : Mouse Brain Lysate


Predicted band size : 36 kDa

References for Anti-CEBP Beta antibody [E299] (ab32358)

This product has been referenced in:

  • Michas G  et al. Reciprocal regulation of 11ß-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro. Mol Cell Biochem 346:69-79 (2011). WB; Human.Read more (PubMed: 20922465) »
  • Pal R  et al. C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells. Blood 114:3890-8 (2009). WB, IHC-P; Human.Read more (PubMed: 19717648) »

See all 3 publications for this product

Publishing research using ab32358? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"